GT Biopharma

+$0.21 (+3.47%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GT Biopharma and other ETFs, options, and stocks.

About GTBP

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells).

CEO
Anthony J. Cataldo
Employees
3
Headquarters
Beverly Hills, California
Founded
1965

GTBP Key Statistics

Market Cap
190.82M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
251.57K
High Today
$6.30
Low Today
$6.02
Open Price
$6.02
Volume
147.02K
52 Week High
$19.73
52 Week Low
$2.55

GTBP Earnings

-$3.40
-$2.27
-$1.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure